top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Hesperos establishes strategic sales partnership with AsedaSciences to augment compound safety prediction
Intra-industry partnerships
Hesperos awarded Phase IIB SBIR grant to investigate drug-induced cognitive impairment using its Human-on-a-Chip®
Grants Awarded & Funds Raised
Genoskin raises $8.7M to advance immunocompetent human skin models
Grants Awarded & Funds Raised
Cedars-Sinai KronosRx team awarded $5M to improve prediction of adverse drug effects
Grants Awarded & Funds Raised
Inductive Bio awarded $21M by ARPA-H to improve drug toxicity prediction
Grants Awarded & Funds Raised
bottom of page
